Ramy Ibrahim
Net worth: 81 725 $ as of 2024-04-29
Career history of Ramy Ibrahim
Former positions of Ramy Ibrahim
Companies | Position | Start | End |
---|---|---|---|
SURFACE ONCOLOGY, INC. | Director/Board Member | 2019-09-16 | 2023-09-07 |
Independent Dir/Board Member | - | 2023-09-07 | |
2SEVENTY BIO, INC. | Director/Board Member | 2021-10-14 | 2023-06-15 |
Independent Dir/Board Member | - | 2023-06-15 | |
BLUEBIRD BIO, INC. | Director/Board Member | 2021-01-06 | 2021-11-03 |
Independent Dir/Board Member | - | 2021-11-03 | |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Chief Tech/Sci/R&D Officer | 2016-06-30 | 2020-12-31 |
ASTRAZENECA PLC | Corporate Officer/Principal | 2014-01-31 | 2016-06-30 |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 2011-03-31 | 2014-01-31 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2005-09-30 | 2011-03-31 |
Bit Bio Ltd.
Bit Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Bit Bio Ltd. engages in research and experimental development on natural sciences and engineering. Its products are human-induced skeletal myocytes and glutamatergic neurons. The company was founded by Mark Kotter in 2016 and is headquartered in Cambridge, the United Kingdom. | Sales & Marketing | 2020-09-30 | - |
Statistics
International
United States | 7 |
United Kingdom | 3 |
Operational
Director/Board Member | 3 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 3 |
Sectoral
Health Technology | 7 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
ASTRAZENECA PLC | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
BLUEBIRD BIO, INC. | Health Technology |
2SEVENTY BIO, INC. | Health Technology |
Private companies | 4 |
---|---|
Surface Oncology, Inc.
Surface Oncology, Inc. BiotechnologyHealth Technology Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company, which engages in the provision of biological pathways critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies. The firm’s pipeline includes wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114). Its pipeline also includes licensed product programs, such as a collaboration with Novartis targeting CD73 (NZV930, Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813, preclinical). The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA. | Health Technology |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Bit Bio Ltd.
Bit Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Bit Bio Ltd. engages in research and experimental development on natural sciences and engineering. Its products are human-induced skeletal myocytes and glutamatergic neurons. The company was founded by Mark Kotter in 2016 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Ramy Ibrahim
- Experience